Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q1 2018 · 10-Q
Revenue$98.60M$98.60M+39.6% vs Q1 2017 Net Income$12.22M$12.22M+98.9% vs Q1 2017 EPS Diluted$1.01$1.01+98.0% vs Q1 2017 Gross Profit$74,808,000+41.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flow$18,008,000+169.5% Free Cash Flowderived$16,722,000+169.1% Margins · derivedGross margin75.9%+1.0 pt vs Q1 2017
Operating margin14.9%+2.7 pt vs Q1 2017
Net margin12.4%+3.7 pt vs Q1 2017
ended Mar 31, 2018 · filed May 4, 2018 · 34 d after period end